Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
PV-001 by Posvax for Human Papillomavirus Infections: Likelihood of Approval
PV-001 is under clinical development by Posvax and currently in Phase I for Human Papillomavirus Infections. According to GlobalData, Phase...
Data Insights
Oncolytic Virus for Human Papillomavirus Associated Cancer, Human Papillomavirus Infections and Coronavirus Disease 2019 (COVID-19) by Blue Sky Immunotherapies for Human Papillomavirus Infections: Likelihood of Approval
Oncolytic Virus for Human Papillomavirus Associated Cancer, Human Papillomavirus Infections and Coronavirus Disease 2019 (COVID-19) is under clinical development by...